Loading organizations...
§ Venture Capital · Los Angeles, CA, USA
Venture capital firm investing in late-stage medical technology and biopharmaceutical companies, focused on Alzheimer's.
Alerce Medical Technology Partners is an investment firm focused on deploying capital strategically within the medical technology sector. It manages funds dedicated to identifying and fostering growth in innovative companies developing advanced healthcare solutions. The firm employs rigorous due diligence and active portfolio management to accelerate market penetration of critical medical technologies.
The firm’s origins trace to Muneer A. Satter, who founded Satter Investment Management LLC in 2012, evolving into Alerce Investment Management in 2016. Satter identified a clear need for a focused investment vehicle to capitalize on and support the burgeoning medical technology landscape, recognizing significant potential for advancements and returns within this specialized industry.
Alerce Medical Technology Partners serves limited partners by offering access to a curated portfolio of high-potential medical technology investments. It empowers portfolio companies with capital and strategic guidance, enabling them to bring transformative healthcare products to market. The firm’s long-term vision is to drive innovation and improve patient outcomes by accelerating adoption of next-generation medical solutions.
Alerce Medical Technology Partners has 1 tracked investment across 1 company. The latest tracked deal is $100.0M Series E in Alzheon in June 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 12, 2024 | Alzheon | $100.0M Series E | Alerce Medical Technology Partners | — |